Elevated concentrations of linoleic acid in erythrocyte membrane phospholipids in patients with inflammatory bowel disease

Nutrition Research

Volumn 28, Issue 4, 2008, Pages 239-244

  Ueda, Yukiko ^a   Kawakami, Yuko ^b   Kunii, Daisuke ^c   Okada, Hiroyuki ^d   Azuma, Masami ^e   Le, Duc Son N T ^f   Yamamoto, Shigeru ^g  

^a NARA WOMEN'S UNIVERSITY   (Japan)

^b Chyugokugakuen University

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d OKAYAMA UNIVERSITY   (Japan)

^e OSAKA KYOIKU UNIVERSITY   (Japan)

^f NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^g OCHANOMIZU UNIVERSITY   (Japan)

Author keywords

Eicosanoids; Erythrocyte membrane phospholipids; Human; Inflammatory bowel disease; n 6 and n 3 fatty acids; Plasma phospholipids; Polyunsaturated fatty acids

Indexed keywords

LINOLEIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PHOSPHOLIPID;

ARTICLE; BODY MASS; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; ERYTHROCYTE MEMBRANE; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; LIPID COMPOSITION; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL ASSESSMENT; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADULT; ANTHROPOMETRY; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; ERYTHROCYTE MEMBRANE; FATTY ACIDS, OMEGA-6; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; LINOLEIC ACID; MALE; PHOSPHOLIPIDS; QUESTIONNAIRES;

EID: 41549164721     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2008.02.005     Document Type: Article

References (38)

1. Andres P.G., and Friedman L.S. Epidemiology and the natural course of inflammatory bowel Disease. Gastroenterol Clin North Am 28 2 (1999) 255-281
2. Whelan G. Epidemiology of inflame bowel diseases. Med Clin North Am 74 (1990) 1-12
3. Yang S.K., Loftus W.J., and Sandborn Jr. E.V. Epidemiology of inflammatory bowel disease in Asia. Inflamm Bowel Dis 7 (2001) 260-270
4. Sakamoto N., Kono S., Wakai K., Fukuda Y., Satomi M., Shimoyama T., et al. Dietary risk factors for inflammatory bowel disease a multicenter case-control study in Japan. Inflamm Bowel Dis 11 (2004) 154-163
5. Elson C.O., and Genes M. T cells-new therapeutic targets in Crohn's disease. N Engl J Med 346 (2002) 614-616
6. Kromann N., and Green A. Epidemiological studies in the Upernavik district, Greenland. Incidence of some chronic diseases 1950-1974. Acta Med Scan 208 (1980) 401-406
7. Donowitz M. Arachidonic acid metabolites and their role in inflammatory bowel disease. Gastroenterology 88 (1985) 580-587
8. Awane M., Li D.J., Andres P.G., and Reinecker H.C. NF-kappa B-inducing kinase is a common mediator of IL-17-, TNF-alpha, and IL-1 beta-induced chemokine promoter activation in intestinal epithelial cells. J Immunol 162 9 (1999) 5337-5344
9. Sharon P., and Stenson W.F. Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease. Gastroenterology 86 (1984) 453-460
10. Budowski P., and Crawford M.A. a-Linolenic acid as a regulator of the metabolism of arachidonic acid: dietary implications of the ratio, n-6: n-3 fatty acid. Proc Nutr Soc 44 (1985) 221-229
11. Adam O., Wolfram G., and Zollner N. Effect of a-linolenic acid in the human diet of linoleic acid metabolism and prostaglandin biosynthesis. F Lipid Res 27 (1986) 421-426
12. Kinsella J.E., Lokesh B., Broughton S., and Whelan J. Dietary polyunsaturated fatty acids and eicosanoids: potential effects on the modulation of inflammatory and immune cells: an overview. Nutrition 6 (1990) 24-44
13. Robinson D.R. Alleviation of autoimmune disease by dietary lipids containing omega-3 fatty acids. Rheum Dis Clin North Am 17 (1991) 213-222
14. Shoda R., Matsueda K., Yamato S., and Umeda N. Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. Am J Clin Nutr 63 5 (1996) 741-745
15. Belluzzi A., Brignola C., Campieri M., Pera A., Boschi S., and Miglioli M. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med 334 (1996) 1557-1560
16. Campbell J.M., Fahey G.C., and Lichtensteiger C.A. An enteral formula containing fish oil, indigestible oligosaccharides, gum Arabic and antioxidants affects plasma and colonic phospholipids fatty acid and prostaglandin profiles in pigs. J Nutr 127 (1997) 137-145
17. Mills D.E., Murthy M., and Galey W.R. Dietary fatty acids, membrane transport and oxidative sensitivity in human erythrocytes. Lipids 30 (1995) 657-663
18. Skeaff M.C., Hodson L., and McKenzie E.J. Dietary-induced changes in fatty acid composition of human plasma, platelet, and erythrocyte lipids follow a similar time course. J Nutr 136 (2006) 565-569
19. Bjerve K.S., Brubakk A.M., and Fougner K.J. Omega-3 fatty acids: essential fatty acids with important biological effects, and serum phospholipids fatty acid as markers of dietary omega-3 fatty acid intake. Am J Clin Nutr 57 (1993) 801s-806s
20. Schachter H., and Kirsner J.B. Definitions of inflammatory bowel disease of unknown etiology. Gastroenterology 68 (1975) 591-600
21. A diagnosis standard examination committee of obesity by JASSO: a committee report about a judgment of new obesity and a diagnosis standard of obesity. Journal of the Study of Obesity 6 (2000) 18-28
22. Suzuki K., Sasagawa T., Okita M., Fujiwara Y., Saito M., and Abe Y. Development of new simplified-food frequency method for use in the surveillance on lifestyle in order to promote healthy condition in Okayama Prefecture, computed by Microsoft Excel. Bull Facul Health Welfare Sci, Okayama Prefec Univ 3 (1996) 143-153
23. Dumas B.T., Watson W.A., and Biggs H.G. Albumins standard and the measurement of serum albumin with bromcresol green. 1971. Clin Chim Acta 3 (1997) 21-30
24. Hanahan D.J., and Ekholm J.E. The preparation of red cell ghosts (membrane). Methods in enzymol 31 (1974) 168-172
25. Blight E.G., and Dyer W.J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37 (1959) 911-917
26. Okita M., Gaudette D.C., Mills G.B., and Holub B.J. Elevated levels and altered fatty acid composition of plasma lysophosphatidylcholine (lysoPC) in ovarian cancer patients. Int J Cancer 71 (1997) 31-34
27. Okita M., Sasagawa T., and Kotani M. Green vegetable juice increases polyunsaturated fattty acid of erythrocyte membrane phospholipids in hypercholesterolaemic patients. Asia Pac J Clin Nutr 9 (2000) 309-313
28. SPSS Inc. SPSS for Windows, Release 11.5; 2000. Chicago.
29. Simopoulos A.P. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 21 6 (2002) 495-505
30. Calder P.C. N-3 polyunsaturated fatty acids, inflammation and immunity: pouring oil on troubled waters or another fishy tale?. Nutr Res 21 (2001) 309-341
31. Pacheco S., Hillier K., and Smith C. Increased arachidonic acid levels in phospholipids of human colonic mucosa in inflammatory bowel disease. Clinical Science 73 (1987) 361-364
32. Lauritsen K., Laursen L.S., Bukhave K., and Rask-Madsen J. In vivo profiles of eicosanoids in ulcerative colitis, Crohn's colitis, and Clostridium difficile colitis. Gastroenterology 95 (1988) 11-17
33. Capritso E., Mingrone G., Addolorato G., Greco A.V., and Gasbarrini G. Metabolic features of inflammatory bo 1 disease in a remission phase of the disease activity. J Intern Med 243 (1998) 339-347
34. Geerling B.J., Badart-Smook A., Stockbrugger R.W., and Brummer R.J. Comprehensive nutritional status in patients with long-standing Crohn disease currently in reemission. Am J Clin Nutr 67 (1998) 819-820
35. Hawkey C.J., Boughton-Smith N.K., and Whittle B.J. Modulation of human colonic arachidonic acid metabolism by sulfasalazine. Dig Dis Sci 30 (1985) 1161-1165
36. Brenner R.R. Nutritional and hormonal factors influencing desaturation of essential fatty acids. Prog Lipid Res 20 (1981) 41-47
37. Hill E.G., and Holman R.T. Effect of dietary protein level upon essential fatty acid deficiency. J Nutr 110 (1980) 1057-1060
38. Tomas M.E., Mercuri O., and Rodrigo A. Effects of dietry protein and EFA deficiency on liver D5, D6 and D9 desaturase activities in the early developing rat. J Nutr 110 (1980) 595-599